Early Phase
Global Clinical Development
Late Phase
Biometrics
Medical & Regulatory Affairs
Resourcing Solutions
SERVICES Early Phase Global Clinical Development Late Phase Biometrics Medical & Regulatory Affairs Medical Affairs Regulatory Affairs Resourcing Solutions
Medical Affairs
Chiltern’s highly experienced global Medical Affairs and Pharmacovigilance teams offer medical monitoring and pharmacovigilance services to assist with monitoring patient safety across all stages of drug development. Our teams are strategically located in Europe, India and USA enabling them to provide 24/7 medical support and pharmacovigilance services. To date, our team has been involved in monitoring more than 50 medicinal products in 40 countries across 1,300 sites.
Medical Monitoring
Our medical monitoring capabilities include the following services:
Working to global pharmacovigilance SOPs while ensuring local compliance, our pharmacovigilance team’s capabilities include the following services:
Medical Monitoring
Our medical monitoring capabilities include the following services:
- Medical monitoring plan preparation
- Medical support for investigator sites and project teams
- 24/7 medical support
- Development and delivery of project training
- Responding to subject eligibility and withdrawal questions
- Medical review of Serious Adverse Events (SAE)
- Assessment of serious adverse event reports with pharmacovigilance
- Review of safety parameters and alert reports
- Medical review of coding
- Medical review of Clinical Study Reports (CSR)
Working to global pharmacovigilance SOPs while ensuring local compliance, our pharmacovigilance team’s capabilities include the following services:
- Start up support
- Development of project-specific safety management plans
- Training at investigator meetings
- Safety database services (in-house or with client system)
- SAE processing for investigational products
- Receipt and follow-up
- Medical assessment
- Narrative preparation
- SAE reconciliation
- AE/SAE processing for licensed products
- Receipt and follow-up
- Medical assessment
- Narrative preparation
- AE/SAE reconciliation
- Literature review
- Signal detection and analysis
- Consultation in risk management activities
- Local / national safety reporting
- Expedited reporting (e.g., preparation of CIOMS/MedWatch reports)
- Full Eudravigilance service – registration, dictionary customisation, reporting
- Periodic line listings for the competent authorities and ethics committees
- Preparation of Periodic Safety Update Reports (PSURs) and US periodic reports
- Medical information (multilingual)
In The Media
Chiltern Announces Its Financial Results For The Year Ended 31 March 2010, 27 July 2010 More
Follow the Project Leader, Chiltern Featured Article in the EPC June 2010 Issue , 30 June 2010 More
Chiltern Launches Collaborative Technologies, 10 June 2010 More
Chiltern Achieves Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency, 7 June 2010 More
Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre, 2 June 2010 More

